Thus, EphB4 loss may shift the balance of signaling and structural components to favor tumor proliferation and metastasis through non-classical EMT pathways that likely involve enhanced Wnt signaling and ECM remodeling. The gene discussed is EPHB4; the disease is neoplasm.